Gyermekkori daganatok: vizsgálatok itt: Izland
4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleCHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
- Where
- Reykjavik
- Életkor
- Up to 64 év
- People
- 675 worldwide
- Run by
- Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-504999-25-00 - No phaseTaking peopleA Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
- Where
- Reykjavik
- Életkor
- 0 év to 45 év
- People
- 500 worldwide
- Run by
- Mats Heyman
See details and how to joinNCT03911128 - 3. fázisTaking peopleA Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
- Where
- Reykjavik
- Életkor
- 0 év to 45 év
- People
- 6430 worldwide
- Run by
- Mats Heyman
See details and how to joinNCT04307576 · EU 2022-501050-11-01 - 2. fázisTaking peopleCHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
- Where
- Reykjavik
- Életkor
- 1 hónap to 18 év
- People
- 60 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06262438 · EU 2023-505000-27-01